Respir First
Natural health product licensed in Canada
- Licence holder
- Gordian Global Marketing Inc. (dba) Gordian Health Products
- NPN or DIN-HM
- 80045124
- Status
- Active licence
- Licence date
- 30 September 2013
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacea purpurea Source : Racine | 750 mg | Not calculated |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 300 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 100 mg | Not calculated |
Non-medicinal ingredients
Feuille d'Eucalyptus globulus, Glycérine, Sorbate de potassium, Benzoate de sodium, Cannelle, Acide citrique, Miel, Eau purifiée, Poudre de girofle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Cuillière(s) à table | 1 day |
Uses authorised in Canada
Used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections. Echinacea is traditionally used in Herbal Medicine to help relieve cold symptoms. Help relieve symptoms (cough, dyspnoea, catarrh) of chronic bronchitis. Help increase the clearance of mucous from the respiratory tract in adults with chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Rare cases of severe allergic reactions have been known to occur.
Source
Official Health Canada record, licence 80045124
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.